Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmonary function safety of Botox in upper limb spasticity due to upper motor neuron syndrome
2005-004834-42Phase 2Completed
- Sponsor
- Allergan
- Start
- Apr 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in upper extremity spasticity and Pyramidal syndrome (PS) comparing Botox with Placebo (2 arms). Primary endpoint: Pulmonary function test assessments. Started Apr 2006; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
upper extremity spasticityPyramidal syndrome (PS)
Beyond the preview
Go deeper on 2005-004834-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004834-42.